Company: RPTX
Filing Date: 2025-03-03
Form Type: 10-K
Source: 0000950170-25-030405
Chunk: 130

Company: Repare Therapeutics Inc.
Filing Date: 2025-03-03
Form: 10-K
Item: Item 1B
Chunk 130
---
 LLC
     
    10-Q
     
    001-39335
     
    10.2
     
    November 7, 2024

    19.1*
     
    Repare Therapeutics Inc. Insider Trading Policy

    21.1
     
    Subsidiaries of the registrant.
     
    S-1
     
    333-238822
     
    21.1
     
    May 29, 2020

    23.1*
     
    Consent of Ernst & Young LLP, an Independent Registered Public Accounting Firm

145

    24.1*
     
    Power of Attorney (incorporated by reference to the signature page of this Annual Report on Form 10-K).

    31.1*
     
    Certification of Principal Executive Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

    31.2*
     
    Certification of Principal Financial Officer Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

    32.1**
     
    Certification Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

    97
     
    Incentive Compensation Recoupment Policy of Repare Therapeutics Inc.
     
    10-K
     
    001-39335
     
    97
     
    February 28, 2024

    101.INS*
     
    Inline XBRL Instance Document

    101.SCH*
     
    Inline XBRL Taxonomy Extension Schema With Embedded Linkbase Documents

    104
     
    Inline Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101)

* Filed herewith.

** This certification is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liability of that section, nor shall it be deemed incorporated by reference